These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6126866)

  • 21. Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-I.
    Kastin AJ; Schally AV; Kostrzewa RM
    Fed Proc; 1980 Sep; 39(11):2931-6. PubMed ID: 6105977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition by L-prolyl-L-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices.
    Scimonelli T; Celis ME
    Peptides; 1982; 3(6):885-9. PubMed ID: 6132363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system.
    Yehuda S; Carasso RL
    Peptides; 1982; 3(2):105-10. PubMed ID: 6124951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-MSH and MIF-2 effects on serotonin levels and accumulation in various rat brain areas.
    Spirtes MA; Kostrzewa RM; Kastin AJ
    Pharmacol Biochem Behav; 1975; 3(6):1011-5. PubMed ID: 4814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas.
    Kostrzewa RM; Kastin AJ; Spirtes MA
    Pharmacol Biochem Behav; 1975; 3(6):1017-23. PubMed ID: 4815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiopioid properties of the TYR-MIF-1 family.
    Bocheva A; Dzambazova-Maximova E
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):673-7. PubMed ID: 15632952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased acquisition of a complex appetitive task after MSH and MIF.
    Stratton LO; Kastin AJ
    Pharmacol Biochem Behav; 1975; 3(5):901-4. PubMed ID: 1801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. alpha-MSH and Pro-Leu-Gly-NH2 (PLG; MIF-1): influence on dopamine (DA) uptake in crude synaptosomal preparations from rat mediobasal hypothalamus (MBH) and caudate putamen (CP).
    Torre E; Celis ME; Chiocchio SR
    Peptides; 1984; 5(4):669-74. PubMed ID: 6149522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine does not change the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Life Sci; 1991; 49(16):1163-8. PubMed ID: 1680211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of melanotrophin release inhibiting factor (MIF) and cyclo (Leu-Gly) on the tolerance to morphine-induced antinociception in the rat: a dose-response study.
    Bhargava HN
    Br J Pharmacol; 1981 Apr; 72(4):707-14. PubMed ID: 6116510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
    Galina ZH; Kastin AJ
    Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in the effects of Tyr-MIF-1 on morphine- and stress-induced analgesia.
    Kavaliers M; Innes DG
    Peptides; 1992; 13(6):1295-7. PubMed ID: 1362981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of three short-chain peptides (alpha-MSH, MSH/ACTH 4-10, MIF-I on) dimensional attention.
    Beckwith BE; Sandman CA; Kastin A
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):11-6. PubMed ID: 13409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MIF-induced augmentation of melatonin functions: possible relevance to mechanisms of action of MIF-1 in movement disorders.
    Sandyk R
    Int J Neurosci; 1990 May; 52(1-2):59-65. PubMed ID: 1979968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigations on alpha-MSH and MIF-1 effects on cyclic AMP levels in rat brain.
    Christensen CW; Harston CT; Kastin AJ; Kostrzewa RM; Spirtes MA
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):117-20. PubMed ID: 13410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged analgesia after intracerebroventricular Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
    Zadina JE; Kastin AJ; Kenigs V; Bruno C; Hackler L
    Neurosci Lett; 1993 Jun; 155(2):220-2. PubMed ID: 8104325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of alpha-MSH and MIF-I with amphetamine on open-field behavior of rats.
    Sandman CA; Kastin AJ
    Pharmacol Biochem Behav; 1978 Dec; 9(6):759-62. PubMed ID: 34173
    [No Abstract]   [Full Text] [Related]  

  • 40. alpha-MSH and MIF-I effects on cGMP levels in various rat brain regions.
    Spirtes MA; Christensen CW; Harston CT; Kastin AJ
    Brain Res; 1978 Apr; 144(1):189-93. PubMed ID: 25119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.